aspirin has been researched along with benzylthiourea in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beattie, D; Brown, M; Campbell, E; Dickenson, F; Ewan, S; Hughes, GA; Ko, SY; Lemaire, M; Lerpiniere, J; Patel, S; Urban, L; Walpole, C | 1 |
1 other study(ies) available for aspirin and benzylthiourea
Article | Year |
---|---|
2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain models.
Topics: Analgesics; Animals; Aspirin; Binding, Competitive; Brain; Drug Design; Guinea Pigs; Humans; Hyperalgesia; Kinetics; Molecular Structure; Naphthalenes; Neurokinin-1 Receptor Antagonists; Pain; Phenylthiourea; Proline; Rabbits; Rats; Receptors, Neurokinin-1; Spectrometry, Mass, Fast Atom Bombardment; Structure-Activity Relationship | 1998 |